Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,425 | -1,347 | -3,847 | -2,243 | N/A |
| Depreciation Amortization | 165 | 72 | 135 | 663 | N/A |
| Accounts receivable | 39 | -493 | 366 | 111 | N/A |
| Other Working Capital | -1,370 | -316 | -482 | -514 | N/A |
| Other Operating Activity | 276 | 660 | 431 | -101 | 0 |
| Operating Cash Flow | $-4,315 | $-1,424 | $-3,397 | $-2,084 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -131 | -26 | -135 | -54 | N/A |
| Other Investing Activity | -18 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-149 | $-26 | $-135 | $-54 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 56 | N/A | N/A |
| Financing Cash Flow | $N/A | $N/A | $56 | $N/A | $N/A |
| Beginning Cash Position | 60,536 | 60,536 | 64,010 | 64,010 | N/A |
| End Cash Position | 56,072 | 59,086 | 60,534 | 61,872 | N/A |
| Net Cash Flow | $-4,464 | $-1,450 | $-3,476 | $-2,138 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,315 | -1,424 | -3,397 | -2,084 | N/A |
| Capital Expenditure | -131 | -26 | -135 | -54 | N/A |
| Free Cash Flow | -4,446 | -1,450 | -3,532 | -2,138 | 0 |